Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143444 |
| CAS No | NA |
| Mol.F. | C17H18N6O3 |
| Mol.Wt. | 354.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143445 |
| CAS No | NA |
| Mol.F. | C9H6N6O |
| Mol.Wt. | 214.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143446 |
| CAS No | NA |
| Mol.F. | C8H7N2O4S |
| Mol.Wt. | 227.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143447 |
| CAS No | NA |
| Mol.F. | C35H31N7O5 |
| Mol.Wt. | 629.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143448 |
| CAS No | NA |
| Mol.F. | C26H28N6O3 |
| Mol.Wt. | 472.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143449 |
| CAS No | NA |
| Mol.F. | C26H28N6O3 |
| Mol.Wt. | 472.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143450 |
| CAS No | NA |
| Mol.F. | C17H21N5O |
| Mol.Wt. | 311.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143451 |
| CAS No | NA |
| Mol.F. | C25H26N6O4 |
| Mol.Wt. | 474.5 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143452 |
| CAS No | NA |
| Mol.F. | C25H26N6O4 |
| Mol.Wt. | 474.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143453 |
| CAS No | NA |
| Mol.F. | C26H28N6O4 |
| Mol.Wt. | 488.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143454 |
| CAS No | NA |
| Mol.F. | C26H28N6O4 |
| Mol.Wt. | 488.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143455 |
| CAS No | NA |
| Mol.F. | C26H25N5O4 |
| Mol.Wt. | 471.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143456 |
| CAS No | NA |
| Mol.F. | C26H26N6O4 |
| Mol.Wt. | 486.53 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143457 |
| CAS No | NA |
| Mol.F. | C26H20ClN5O3 |
| Mol.Wt. | 485.93 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143458 |
| CAS No | NA |
| Mol.F. | C19H26Cl2N4O4 |
| Mol.Wt. | 445.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143459 |
| CAS No | NA |
| Mol.F. | C26H28N4O7 |
| Mol.Wt. | 508.53 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |